ETP for Pharmaceutical Industry

Pharmaceutical manufacturing generates some of the most technically challenging industrial wastewater in India. Unlike food industry ETP where the organic load is high but biodegradable, pharma ETP must contend with Active Pharmaceutical Ingredients (APIs), organic solvents (methanol, acetone, isopropanol, ethyl acetate), residual antibiotics, and synthesis by-products — many of which are biologically inhibitory or refractory to conventional biological treatment. India's pharmaceutical manufacturing belt — Hyderabad's Genome Valley, Baddi in Himachal Pradesh, Ankleshwar in Gujarat, and the Dombivali-Ambernath industrial belt in Maharashtra — generates particularly complex mixed effluent streams. CPCB classifies pharmaceutical bulk drug manufacturers as Red category, requiring SPCB consent with COD limits typically ≤250 mg/L and, increasingly, ZLD mandates.

Pharma wastewater is characterised by a low BOD:COD ratio (typically 0.1–0.3), high solvent content, variable composition depending on the product being manufactured, and the presence of compounds specifically designed to be biologically active. The same properties that make an antibiotic effective in medicine — its ability to kill bacteria — make it toxic to the microbial community in a biological ETP. Solvent recovery is typically performed before wastewater reaches the ETP, but residual solvents remain and contribute to refractory COD. Wastewater generation is often batch-based, creating extreme flow and concentration variability between production runs.

Spans Envirotech has designed ETP systems for pharmaceutical manufacturers including bulk drug, formulation, and biopharmaceutical facilities. Our pharma ETP designs invariably include an advanced oxidation stage — ozonation, Fenton reaction, or UV/H₂O₂ — to break down refractory compounds and raise the BOD:COD ratio before biological treatment. For GPCB-mandated ZLD clients in Gujarat and pharma clusters in Telangana under TSPCB direction, we integrate multi-effect evaporation or mechanical vapour recompression as the ZLD final stage. See our pharmaceuticals industry page and ZLD technology page for detailed information.